BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18183304)

  • 1. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
    Rolland M; Heckerman D; Deng W; Rousseau CM; Coovadia H; Bishop K; Goulder PJ; Walker BD; Brander C; Mullins JI
    PLoS One; 2008 Jan; 3(1):e1424. PubMed ID: 18183304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
    Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
    Littaua RA; Oldstone MB; Takeda A; Debouck C; Wong JT; Tuazon CU; Moss B; Kievits F; Ennis FA
    J Virol; 1991 Aug; 65(8):4051-6. PubMed ID: 1712857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
    Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.
    Buggert M; Norström MM; Czarnecki C; Tupin E; Luo M; Gyllensten K; Sönnerborg A; Lundegaard C; Lund O; Nielsen M; Karlsson AC
    PLoS One; 2012; 7(7):e39874. PubMed ID: 22792193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.
    Gesprasert G; Wichukchinda N; Mori M; Shiino T; Auwanit W; Sriwanthana B; Pathipvanich P; Sawanpanyalert P; Miura T; Auewarakul P; Thitithanyanont A; Ariyoshi K
    PLoS One; 2010 Jun; 5(6):e11179. PubMed ID: 20567513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
    Matthews PC; Koyanagi M; Kløverpris HN; Harndahl M; Stryhn A; Akahoshi T; Gatanaga H; Oka S; Juarez Molina C; Valenzuela Ponce H; Avila Rios S; Cole D; Carlson J; Payne RP; Ogwu A; Bere A; Ndung'u T; Gounder K; Chen F; Riddell L; Luzzi G; Shapiro R; Brander C; Walker B; Sewell AK; Reyes Teran G; Heckerman D; Hunter E; Buus S; Takiguchi M; Goulder PJ
    J Virol; 2012 Dec; 86(23):12643-54. PubMed ID: 22973023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM;
    J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.